Tuesday, November 5, 2024
Most of us are exhausted from pandemic news. Unfortunately, it’s not over just yet. All as the number of Omicron cases nearly doubled over the last few days. In fact, reports CNBC: “The omicron variant is raging across the world as the winter holiday season approaches. The strain has been found through testing in 43 […]
During the first half of 2021, stocks climbed higher in a very linear fashion. It was a great time to watch your investment account balances, but not so good if you like to “buy the dip,” since there never seemed to be a dip. Now in the waning days of summer, fears of a broader […]
Two of the big COVID vaccine producers, Moderna (MRNA) and Pfizer (PFE), saw a significant amount of options activity last week. On one day, with MRNA down nearly 6%, its options traded 4x the normal volume. Most of the activity was still on the call side of things though, which tends to be a bullish […]
The world economy was basically on hold for more than a year due to the coronavirus pandemic (and now variants of the virus that causes COVID-19). Some countries, like the U.S., are mostly back to normal operations. Other countries are still dealing with lockdowns and widespread infections due to a lack of vaccinations. Overall, though, […]
Shares of Pfizer (PFE) are down 20% from their early December 52-week peak at $43.08 and have been hovering around their 200-day moving average for seven-straight sessions. There is still risk towards the $34.25 down to $34 area on continued weakness with the recent low tapping $34.27 earlier this month. There are a number of […]
Pfizer (PFE) has been a hot stock this year as it is the first company to get a Covid-19 vaccine to the market. While a vaccine isn’t going to make or break a pharmaceutical giant like PFE, it certainly isn’t going to hurt the bottom line either. PFE stock has had a decent year so […]
Last week was one for the stock market record books. Market indexes exploded higher from Monday into Tuesday. Stocks gave back some of the gains on Wednesday and Thursday. Then the markets closed out the week with a positive day. The interesting part was the magnitude of the moves and the pandemic-related news that triggered […]
Although the U.S. elections are garnering most of the media attention, the bigger deal for investors is the potential success of a coronavirus vaccine. The Pfizer (PFE) and BioNTech (BNTX) vaccine, with its 90% success rate in trials, could be a significant game changer for a world desperately seeking to find its way out of […]
There was great news this week about the novel coronavirus vaccine being developed by Pfizer (PFE) and Germany’s BioNTech (BNTX). The vaccine has been found to be more than 90% effective, and, if approved, it will be the first vaccine ever that uses novel mRNA technology. These results (although early and not independently vetted) far […]
